Drug Profile
Exenatide oral - Shanghai Biolaxy
Alternative Names: NodexenLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Shanghai Biolaxy
- Class Antihyperglycaemics; Obesity therapies; Peptides; Venoms
- Mechanism of Action Glucagon like peptide 1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Diabetes-mellitus in China (PO)
- 06 Apr 2016 Phase I development is ongoing in China
- 23 Jan 2015 Phase-I clinical trials in Diabetes mellitus in China (PO) before January 2015